Suzy Madar
The Treaty on IP, Genetic Resources and Associated Traditional Knowledge has been tabled in Parliament
22 May 2026
Just over a year ago, we wrote about the adoption of the Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge (the Treaty) by 150 members states of the World Intellectual Property Organization (WIPO) and what it could mean for Australia: read our earlier post here.
Read on
Digging too deep: When patent amendments become an abuse of process
24 April 2026
This is a short note to report on a successful interlocutory application seeking a declaration that a patent amendment amounted to an abuse of process.
Read on
The TGA’s medicinal cannabis products review: what stakeholders said and what comes next
19 March 2026
The Therapeutic Goods Administration (TGA) has released its response to the feedback it received to its consultation on the safety and regulatory oversight of unapproved medicinal cannabis products.
Read on
CPC v Apple: Appeal in funded patent litigation
5 March 2026
CPC Patents Technologies’ (CPC) appeal of the Federal Court’s decision in CPC Patent Technologies Pty Ltd v Apple Pty Limited [2025] FCA 489 was heard in the Federal Court earlier this week.
Read on
Federal Court grants urgent interlocutory injunction in dapagliflozin dispute
24 February 2026
On 16 February 2026, the Federal Court of Australia granted an urgent interlocutory injunction restraining Pharmacor from launching and listing generic dapagliflozin products on the PBS.
Read on
New TGA guidance on the regulation of AI-based software medical devices
17 February 2026
Opportunities for the application of AI in health and life sciences continue to grow.
Read on
Special leave in Aristocrat refused: Australia’s approach to patentability of CIIs settled
11 February 2026
Following the High Court’s refusal of special leave to the Commissioner of Patents on 5 February 2026, Australia now has a clear position on computer-implemented inventions (CIIs): the Full Federal Court’s September 2025 articulation of the test in Aristocrat Technologies Australia Pty Ltd v Commissioner of Patents[1] remains the settled law.
Read on
Federal Court grants first preliminary injunction to pharma patentee in 7 years
28 January 2026
On 5 December 2025, the Federal Court of Australia granted an interlocutory injunction restraining the launch and Pharmaceutical Benefits Scheme (PBS) listing of generic long-acting injectable (LAI) paliperidone palmitate products.
Read on
Australia reformulates its position on patent term extensions
15 December 2025
The Full Federal Court of Australia has determined that pharmaceutical formulations are not eligible for patent term extension in Australia.
Read on
Load More Posts